Prevalence of high-risk individuals for breast/ovarian cancer in a general Iranian female population using the International Breast Cancer Intervention Study (IBIS) risk calculation tool

Objectives: Various risk assessment tools have been developed to evaluate the risk of hereditary breast/ovarian cancer. This study aims to estimate the risk of breast/ovarian cancer in a sample of the general population in Iran using the IBIS software.Methods: A total of 2020 women aged 18-79 years...

Full description

Bibliographic Details
Main Authors: Maliheh Arab, Elena Ghotbi, Giti Noghabaei, Behnaz Ghavami, Tayebeh Jahed Bozorgan, Behnaz Nouri
Format: Article
Language:English
Published: Kashan University of Medical Sciences 2024-04-01
Series:International Archives of Health Sciences
Subjects:
Online Access:http://iahsj.kaums.ac.ir/article_193292_817a511166f31fd4bb8d25d2b8f1acfd.pdf
_version_ 1797220365317963776
author Maliheh Arab
Elena Ghotbi
Giti Noghabaei
Behnaz Ghavami
Tayebeh Jahed Bozorgan
Behnaz Nouri
author_facet Maliheh Arab
Elena Ghotbi
Giti Noghabaei
Behnaz Ghavami
Tayebeh Jahed Bozorgan
Behnaz Nouri
author_sort Maliheh Arab
collection DOAJ
description Objectives: Various risk assessment tools have been developed to evaluate the risk of hereditary breast/ovarian cancer. This study aims to estimate the risk of breast/ovarian cancer in a sample of the general population in Iran using the IBIS software.Methods: A total of 2020 women aged 18-79 years were consecutively selected from the gynecology clinic of Imam Hossein Medical Center between April 2019 and 2021. The Tyrer-Cusick (IBIS) questionnaire was used to collect data on variables such as age, BMI, age at menarche, age at first pregnancy, menopausal status, history of hormone replacement therapy (HRT), and family history of breast/ovarian cancer. The risks of developing breast/ovarian cancer were calculated, with patients having a calculated risk of more than 20% considered high-risk and those below 20% considered low-risk.Results: Out of the 2020 cases studied, 69 (3.4%) were classified as high-risk for developing breast/ovarian cancer. The moderate risk of breast/ovarian cancer in patients with a positive family history was 18.47%, compared to 10.15% in those without a family history. All high-risk individuals had a positive family history, while only 9.4% of the low-risk population had a family history; this difference was statistically significant (p<0.001).Conclusion: Routine assessment of family history of cancer in all patients is recommended, with positive cases being further evaluated using a cancer risk assessment tool and referred for genetic counseling as appropriate.
first_indexed 2024-04-24T12:48:23Z
format Article
id doaj.art-d3091e9aa6fd49ac9d7a4c1100b22ab3
institution Directory Open Access Journal
issn 2383-2568
language English
last_indexed 2024-04-24T12:48:23Z
publishDate 2024-04-01
publisher Kashan University of Medical Sciences
record_format Article
series International Archives of Health Sciences
spelling doaj.art-d3091e9aa6fd49ac9d7a4c1100b22ab32024-04-06T16:38:37ZengKashan University of Medical SciencesInternational Archives of Health Sciences2383-25682024-04-0111211512110.48307/iahsj.2024.405022.1003193292Prevalence of high-risk individuals for breast/ovarian cancer in a general Iranian female population using the International Breast Cancer Intervention Study (IBIS) risk calculation toolMaliheh Arab0Elena Ghotbi1Giti Noghabaei2Behnaz Ghavami3Tayebeh Jahed Bozorgan4Behnaz Nouri5Department of Obstetrics and Gynecology, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, IranDepartment of Obstetrics and Gynecology, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, IranInternist, Iran University of Medical Science, Tehran, IranObstetrician and Gynecologist, Fellowship of laparoscopy, Tehran University of Medical Sciences, Tehran, IranDepartment of Obstetrics and Gynecology, Mahdieh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranDepartment of Obstetrics and Gynecology, Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranObjectives: Various risk assessment tools have been developed to evaluate the risk of hereditary breast/ovarian cancer. This study aims to estimate the risk of breast/ovarian cancer in a sample of the general population in Iran using the IBIS software.Methods: A total of 2020 women aged 18-79 years were consecutively selected from the gynecology clinic of Imam Hossein Medical Center between April 2019 and 2021. The Tyrer-Cusick (IBIS) questionnaire was used to collect data on variables such as age, BMI, age at menarche, age at first pregnancy, menopausal status, history of hormone replacement therapy (HRT), and family history of breast/ovarian cancer. The risks of developing breast/ovarian cancer were calculated, with patients having a calculated risk of more than 20% considered high-risk and those below 20% considered low-risk.Results: Out of the 2020 cases studied, 69 (3.4%) were classified as high-risk for developing breast/ovarian cancer. The moderate risk of breast/ovarian cancer in patients with a positive family history was 18.47%, compared to 10.15% in those without a family history. All high-risk individuals had a positive family history, while only 9.4% of the low-risk population had a family history; this difference was statistically significant (p<0.001).Conclusion: Routine assessment of family history of cancer in all patients is recommended, with positive cases being further evaluated using a cancer risk assessment tool and referred for genetic counseling as appropriate.http://iahsj.kaums.ac.ir/article_193292_817a511166f31fd4bb8d25d2b8f1acfd.pdfbreast cancerovarian cancerrisk assessment toolibis
spellingShingle Maliheh Arab
Elena Ghotbi
Giti Noghabaei
Behnaz Ghavami
Tayebeh Jahed Bozorgan
Behnaz Nouri
Prevalence of high-risk individuals for breast/ovarian cancer in a general Iranian female population using the International Breast Cancer Intervention Study (IBIS) risk calculation tool
International Archives of Health Sciences
breast cancer
ovarian cancer
risk assessment tool
ibis
title Prevalence of high-risk individuals for breast/ovarian cancer in a general Iranian female population using the International Breast Cancer Intervention Study (IBIS) risk calculation tool
title_full Prevalence of high-risk individuals for breast/ovarian cancer in a general Iranian female population using the International Breast Cancer Intervention Study (IBIS) risk calculation tool
title_fullStr Prevalence of high-risk individuals for breast/ovarian cancer in a general Iranian female population using the International Breast Cancer Intervention Study (IBIS) risk calculation tool
title_full_unstemmed Prevalence of high-risk individuals for breast/ovarian cancer in a general Iranian female population using the International Breast Cancer Intervention Study (IBIS) risk calculation tool
title_short Prevalence of high-risk individuals for breast/ovarian cancer in a general Iranian female population using the International Breast Cancer Intervention Study (IBIS) risk calculation tool
title_sort prevalence of high risk individuals for breast ovarian cancer in a general iranian female population using the international breast cancer intervention study ibis risk calculation tool
topic breast cancer
ovarian cancer
risk assessment tool
ibis
url http://iahsj.kaums.ac.ir/article_193292_817a511166f31fd4bb8d25d2b8f1acfd.pdf
work_keys_str_mv AT maliheharab prevalenceofhighriskindividualsforbreastovariancancerinageneraliranianfemalepopulationusingtheinternationalbreastcancerinterventionstudyibisriskcalculationtool
AT elenaghotbi prevalenceofhighriskindividualsforbreastovariancancerinageneraliranianfemalepopulationusingtheinternationalbreastcancerinterventionstudyibisriskcalculationtool
AT gitinoghabaei prevalenceofhighriskindividualsforbreastovariancancerinageneraliranianfemalepopulationusingtheinternationalbreastcancerinterventionstudyibisriskcalculationtool
AT behnazghavami prevalenceofhighriskindividualsforbreastovariancancerinageneraliranianfemalepopulationusingtheinternationalbreastcancerinterventionstudyibisriskcalculationtool
AT tayebehjahedbozorgan prevalenceofhighriskindividualsforbreastovariancancerinageneraliranianfemalepopulationusingtheinternationalbreastcancerinterventionstudyibisriskcalculationtool
AT behnaznouri prevalenceofhighriskindividualsforbreastovariancancerinageneraliranianfemalepopulationusingtheinternationalbreastcancerinterventionstudyibisriskcalculationtool